A comparative study on different treatment methods for patients with perimenopausal uterine fibroids

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400079347

Enrollment

Unknown

Registered

2024-01-01

Start date

2024-01-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine myoma

Interventions

Perimenopausal group:myomectomy

Reproductive age:myomectomy

Eligibility

Sex/Gender

Female

Age

45 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients with uterine fibroids in the age range of 45 to 55; 2. Hysteroscopy excludes endometrial lesions; 3. Cervical screening excludes cervical lesions; 4. Postoperative pathology confirmed uterine leiomyoma.

Exclusion criteria

Exclusion criteria: 1.Patients who have had their uterus removed due to other diseases; 2.Patients with mental illness or cognitive impairment;

Design outcomes

Primary

Measure	Time frame
volume of uterine;	—

Countries

China

Contacts

Public ContactLi Cong

the First Affiliated Hospital of Chongqing Medical University

b05104@126.com+86 153 3450 6105

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026